Stemline Therapeutics (STML) Files $50M IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Stemline Therapeutics (STML) Sees IPO Price of $10 - $12/Share
October 22, 2012 6:00 PM EDTStemline Therapeutics (Nasdaq: STML) filed an amended registration with the U.S. SEC for an Initial Public Offering of its Common Stock. The company plans to sell 1,819,000 shares and sees an offering price of $10 to $12 per share. The company plans to list on the... More
